Synthesis of gatifloxacin, an important fluoroquinolone antibiotic using continuous flow technology
- Authors: Moyo, McQuillan
- Date: 2024-04
- Subjects: Antibiotics , Drug resistance in microorganisms , Chemical processes
- Language: English
- Type: Doctoral theses , text
- Identifier: http://hdl.handle.net/10948/64204 , vital:73664
- Description: Gatifloxacin belongs to an important class of antibiotics known as fluoroquinolones (the fourth generation). Bristol-Myers Squibb (BMS) introduced gatifloxacin to the market in 1999 under the brand name Tequin® for treating respiratory tract infections. It has recently been widely employed as an ophthalmic solution for treating bacterial conjunctivitis. There is limited literature describing the complete synthesis of gatifloxacin; however, ciprofloxacin, a similar fluoroquinolone, has received much attention recently and is a good guide in the synthesis. Even though there are several similarities between ciprofloxacin and gatifloxacin, key reactions towards the synthesis of gatifloxacin have not been reported, which forms a knowledge gap, for instance, the three steps leading to the synthesis of the benzoyl chloride intermediate. It is estimated that 70-90 % of the active pharmaceutical ingredients (APIs) in drugs consumed in sub-Saharan Africa are imported, mainly from India, China and Europe. To reduce dependence and improve access to life-saving drugs, Africa needs to develop cutting-edge technology that is more advanced than traditional means. We envisage that employing continuous flow technology in synthesising gatifloxacin, previously developed in a batch setup, will offer an improved, future-proof process. Thus, this research aimed to create a more efficient multi-step continuous flow process for synthesising gatifloxacin compared to the current batch methods. The first chapter of this thesis provides an extensive literature review on the synthesis of gatifloxacin and its sister drug, ciprofloxacin. The foreground is based on the manufacture and consumption of APIs, particularly antibiotics. Continuous flow technology is also introduced and discussed as the solution to bridging the gap in Africa’s demand for API manufacturing, which significantly lags. Chapter two describes the results and discusses findings on the continuous flow synthesis of gatifloxacin. A seven-step process is described with reaction optimisation studies for each step, starting from 2,4,5-trifluoro-3-hydroxybenzoic acid. An alternative shorter route (with six steps) is also offered, incorporating microwave-assisted technology instead of the traditional batch process. We also describe several elegant multistep processes for synthesising gatifloxacin and its intermediates, achieved by combining several compatible, optimised steps. Subsequently, Chapter 3 describes all the experimental details of our research. In this study, efficient continuous flow procedures were developed to synthesise gatifloxacin. The seven-step continuous flow procedure we developed afforded gatifloxacin (54 % overall isolated yield) in a total residence time of 15.6 mins, a significant improvement from the reported batch process (52 % overall yield and over 103 hours reaction time). , Thesis (PhD) -- Faculty of Science, School of Biomolecular & Chemical Sciences, 2024
- Full Text:
- Date Issued: 2024-04
- Authors: Moyo, McQuillan
- Date: 2024-04
- Subjects: Antibiotics , Drug resistance in microorganisms , Chemical processes
- Language: English
- Type: Doctoral theses , text
- Identifier: http://hdl.handle.net/10948/64204 , vital:73664
- Description: Gatifloxacin belongs to an important class of antibiotics known as fluoroquinolones (the fourth generation). Bristol-Myers Squibb (BMS) introduced gatifloxacin to the market in 1999 under the brand name Tequin® for treating respiratory tract infections. It has recently been widely employed as an ophthalmic solution for treating bacterial conjunctivitis. There is limited literature describing the complete synthesis of gatifloxacin; however, ciprofloxacin, a similar fluoroquinolone, has received much attention recently and is a good guide in the synthesis. Even though there are several similarities between ciprofloxacin and gatifloxacin, key reactions towards the synthesis of gatifloxacin have not been reported, which forms a knowledge gap, for instance, the three steps leading to the synthesis of the benzoyl chloride intermediate. It is estimated that 70-90 % of the active pharmaceutical ingredients (APIs) in drugs consumed in sub-Saharan Africa are imported, mainly from India, China and Europe. To reduce dependence and improve access to life-saving drugs, Africa needs to develop cutting-edge technology that is more advanced than traditional means. We envisage that employing continuous flow technology in synthesising gatifloxacin, previously developed in a batch setup, will offer an improved, future-proof process. Thus, this research aimed to create a more efficient multi-step continuous flow process for synthesising gatifloxacin compared to the current batch methods. The first chapter of this thesis provides an extensive literature review on the synthesis of gatifloxacin and its sister drug, ciprofloxacin. The foreground is based on the manufacture and consumption of APIs, particularly antibiotics. Continuous flow technology is also introduced and discussed as the solution to bridging the gap in Africa’s demand for API manufacturing, which significantly lags. Chapter two describes the results and discusses findings on the continuous flow synthesis of gatifloxacin. A seven-step process is described with reaction optimisation studies for each step, starting from 2,4,5-trifluoro-3-hydroxybenzoic acid. An alternative shorter route (with six steps) is also offered, incorporating microwave-assisted technology instead of the traditional batch process. We also describe several elegant multistep processes for synthesising gatifloxacin and its intermediates, achieved by combining several compatible, optimised steps. Subsequently, Chapter 3 describes all the experimental details of our research. In this study, efficient continuous flow procedures were developed to synthesise gatifloxacin. The seven-step continuous flow procedure we developed afforded gatifloxacin (54 % overall isolated yield) in a total residence time of 15.6 mins, a significant improvement from the reported batch process (52 % overall yield and over 103 hours reaction time). , Thesis (PhD) -- Faculty of Science, School of Biomolecular & Chemical Sciences, 2024
- Full Text:
- Date Issued: 2024-04
Synthesis of L-menthyl glyoxylate, an important intermediate in the manufacture of ARVS, using flow chemistry technology
- Authors: Moyo, McQuillan
- Date: 2017
- Subjects: Chemistry , Pharmaceutical chemistry , Organic compounds -- Synthesis
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: http://hdl.handle.net/10948/12019 , vital:27018
- Description: Herein an alternative approach to the conventional batch synthesis of L-menthyl glyoxylate hydrate (MGH), an important intermediate in the synthesis of drugs of importance is reported, through flow chemistry technology. MGH was initially synthesized in batch and various reaction parameters optimized. It was found to proceed to completion after 6 hours of esterifying glyoxylic acid with excess alcohol (L-menthol) in the presence of a catalyst, ideally amberlyst-15 (an ion exchange resin) at 105 °C giving a yield of 72 %. The batch reaction conditions were adopted in a continuous flow synthesis setup, using the Labtrix Start system, in which reaction conditions were optimized. The optimization of glyoxylic acid conversion (92 %) in the Labtrix Start system gave reaction conditions that resulted in low MGH selectivity (25 %) whereas the optimization for MGH selectivity (100 %) gave a conversion a poor glyoxylic acid conversion (15 %). The FlowSyn system fitted with a column reactor gave the best results, in which the optimum conditions were an excess of L-menthol (1.5 M, 6.0 equiv.), temperature (80 °C) and a residence time of 2.5 minutes with a high selectivity (77 %) and average conversion (50 %). The optimized reaction conditions for conversion and selectivity on the different flow systems did not vary significantly and similar trends were observed for the systems. It was shown that an increase in temperature, mole equivalents and residence time led to an increase in MGH conversion in all flow systems. The scale up of the esterification reaction from the Labtrix Start system (19 μL microreactor) to the FlowSyn system fitted with a 2 mL reactor chip, showed that the reaction proceeds with a slight drop in selectivity from 100 % to 92 % while conversion dropped from 15 to 12 %. On the contrary, a significant drop in conversion and selectivity were observed when the FlowSyn column reactor was up-scaled to the Elite-tubular furnace, owing to the poor mixing in the larger channel size reactor.
- Full Text:
- Date Issued: 2017
- Authors: Moyo, McQuillan
- Date: 2017
- Subjects: Chemistry , Pharmaceutical chemistry , Organic compounds -- Synthesis
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: http://hdl.handle.net/10948/12019 , vital:27018
- Description: Herein an alternative approach to the conventional batch synthesis of L-menthyl glyoxylate hydrate (MGH), an important intermediate in the synthesis of drugs of importance is reported, through flow chemistry technology. MGH was initially synthesized in batch and various reaction parameters optimized. It was found to proceed to completion after 6 hours of esterifying glyoxylic acid with excess alcohol (L-menthol) in the presence of a catalyst, ideally amberlyst-15 (an ion exchange resin) at 105 °C giving a yield of 72 %. The batch reaction conditions were adopted in a continuous flow synthesis setup, using the Labtrix Start system, in which reaction conditions were optimized. The optimization of glyoxylic acid conversion (92 %) in the Labtrix Start system gave reaction conditions that resulted in low MGH selectivity (25 %) whereas the optimization for MGH selectivity (100 %) gave a conversion a poor glyoxylic acid conversion (15 %). The FlowSyn system fitted with a column reactor gave the best results, in which the optimum conditions were an excess of L-menthol (1.5 M, 6.0 equiv.), temperature (80 °C) and a residence time of 2.5 minutes with a high selectivity (77 %) and average conversion (50 %). The optimized reaction conditions for conversion and selectivity on the different flow systems did not vary significantly and similar trends were observed for the systems. It was shown that an increase in temperature, mole equivalents and residence time led to an increase in MGH conversion in all flow systems. The scale up of the esterification reaction from the Labtrix Start system (19 μL microreactor) to the FlowSyn system fitted with a 2 mL reactor chip, showed that the reaction proceeds with a slight drop in selectivity from 100 % to 92 % while conversion dropped from 15 to 12 %. On the contrary, a significant drop in conversion and selectivity were observed when the FlowSyn column reactor was up-scaled to the Elite-tubular furnace, owing to the poor mixing in the larger channel size reactor.
- Full Text:
- Date Issued: 2017
- «
- ‹
- 1
- ›
- »